Full Access
Programmed Stimulation-Guided Therapy Compared with Implantable Cardioverter Defibrillator Device Therapy in the Treatment of Ventricular Tachyarrhythmias
PAUL J. TROUP,
Corresponding Author
PAUL J. TROUP
Section of Cardiology, University of Wisconsin Medical School, Milwaukee Clinical Campus, Sinai Samaritan Medical Center, Milwaukee, Wisconsin
Address for reprints: Paul J. Troup, M.D., University of Wisconsin Medical School, Milwaukee Clinical Campus, Sinai Samaritan Medical Center, 950 North 12th Street, Milwaukee, WI 53233.Search for more papers by this authorPAUL J. TROUP,
Corresponding Author
PAUL J. TROUP
Section of Cardiology, University of Wisconsin Medical School, Milwaukee Clinical Campus, Sinai Samaritan Medical Center, Milwaukee, Wisconsin
Address for reprints: Paul J. Troup, M.D., University of Wisconsin Medical School, Milwaukee Clinical Campus, Sinai Samaritan Medical Center, 950 North 12th Street, Milwaukee, WI 53233.Search for more papers by this author
References
- 1 Swerdlow CD, Winkle RA, Mason JW. Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med 1983; 308: 1436–1442.
- 2 Wilber DJ, Garan H, Finkelstein D, et al. Out of hospital cardiac arrest: use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988; 318: 19–24.
- 3 Liem LB, Swerdlow CD. Value of electropharmalogic testing in idiopathic dilated cardiomyopathy and ventricular tachyarrhythmias. Am J Cardiol 1988; 62: 611–616.
- 4
Bonnet CA,
Elson JJ,
Fogoros RN.
Prognostic significance of noninducibility during baseline electrophysiology study vs. noninducibility during serial drug testing in cardiac arrest survivors.
J Am Coll Cardiol
1990; 15: 124A.
10.1016/0735-1097(90)92211-J Google Scholar
- 5 Milner PC, Dimarco JP, Lerman BB. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. PACE 1988; 11: 562–568.
- 6 Mitchell LB, Duff HJ, Manyari DE, et al. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. N Engl J Med 1987; 317: 1681–1687.
- 7 Roy D, Waxman HL, Kienzle MG, et al. Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: Relation to inducibility at electrophysiologic testing. Am J Cardiol 1983; 52: 969–974.
- 8 Skale BT, Miles WM, Heger JJ, et al. Survivors of cardiac arrest: Prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring. Am J Cardiol 1986; 57: 113–119.
- 9 Morady F, Scheinman MM, Hess DS, et al. Electrophysiologic testing in the management of out-of-hospital cardiac arrest. Am J Cardiol 1983; 54: 85–89.
- 10 Platia EV, Reid PR. Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holler) monitoring in the management of ventricular tachycardia and ventricular fibrillation. J Am Coll Cardiol 1984; 4: 493–500.
- 11 Benditt DG, Benson DW, Klein GJ, et al. Prevention of recurrent sudden cardiac arrest: Role of provocative electropharmacologic testing. J Am Coll Cardiol 1983; 2: 418–425.
- 12 Kim SG, Seiden SW, Felder SD, et al. Is programmed stimulation of value in predicting the long-term success of antiarrhythmic therapy for ventricular tachycardias N Engl J Med 1986; 315: 356–362.
- 13 Rae AP, Spielman SR, Kutalek SP, et al. Electro-physiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy. Am J Cardiol 1987; 59: 291–295.
- 14 Waller TJ, Kay HR, Spielman SR, et al. Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: Criteria of efficacy in patients with sustained ventricular tachyarrhythmia. J Am Coll Cardiol 1987; 10: 83–89.
- 15 Eldar M, Sauve MJ, Scheinman MM. Electrophysiologic testing and follow-up of patients with aborted sudden death. J Am Coll Cardiol 1987; 10: 291–298.
- 16 Freedman RA, Swerdlow CD, Soderholm-Difatte V, et al. Prognostic significance of arrhythmia in-ducibility or noninducibility at initial electrophysiologic study in survivors of cardiac arrest. Am J Cardiol 1988; 61: 578–582.
- 17 Poll DS, Marchlinski FE, Buxton AE, et al. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986; 58: 992–997.
- 18 Kehoe R, Tommasso C, Zheutlin T, et al. Factors determining programmed stimulation responses and long-term arrhythmic outcome in survivors of ventricular fibrillation with ischemic heart disease. Am Heart J 1988; 116: 355–363.
- 19 Zheutlin TA, Steinman RT, Mattioni TA, et al. Long-term arrhythmic outcome in survivors of ventricular fibrillation with absence of inducible ventricular tachycardia. Am J Cardiol 1988; 62: 1213–1217.
- 20 Swerdlow CD, Freedman RA, Peterson J, et al. Determinants of prognosis in ventricular tachyarrhythmia patients without induced sustained arrhythmias. Am Heart J 1986; 111: 433–438.
- 21 Morady F, DiCarlo L, Winston S, et al. Clinical features and prognosis of patients with out of hospital cardiac arrest and a normal electrophysiologic study. J Am Coll Cardiol 1984; 4: 39–44.
- 22 Winkle RA, Mead RH, Ruder MA, et al: Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 13: 1353–1361.
- 23 Reid PR, Griffith LSC, Platia EV, et al. The automatic implantable cardioverter-defibrillator: five year clinical results. In G Breithardt, M. Borggrefe (eds.): Nonpharmacologic Treatment of Tachyarrhythmias. Futura Publishing Co., Inc., Mount Kisco , New York , 1987, pp. 477–486.
- 24 Fogoros RN, Elson JJ, Bonnet CA. Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator. PACE 1989; 12: 1465–1473.
- 25 Tchou PJ, Kadri N, Anderson J, et al: Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med 1988; 109: 529–534.
- 26 Kelly PA, Cannom DS, Garan H, et al. The automatic implantable cardioverter-defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 1988; 11: 1278–1286.
- 27 Myerburg RJ, Luceri RM, Thurer R, et al. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 14: 508–514.
- 28 Manolis AS, Tan-DeGuzman W, Lee MA, et al. Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillator. Am Heart J 1989; 118: 445–449.
- 29 Hargrove WC, Josephson ME, Marchlinski FE, et al. Surgical decisions in the management of sudden cardiac death and malignant ventricular arrhythmias. J Thorac Cardiovasc Surg 1989; 97: 923–928.
- 30 Gabry MD, Brodman R, Johnston D, et al. Automatic implantable cardioverter-defibrillator: Patient survival, battery longevity, and shock delivery analysis. J Am Coll Cardiol 1987; 9: 1349–1356.
- 31 Barbola J, Denes P, Ezri MD, et al. The automatic implantable cardioverter-defibrillator: Clinical experience, complications, and follow-up in 25 patients. Arch Intern Med 1988; 148: 70–76.
Citing Literature
